Results 131 to 140 of about 4,256 (179)

Multi-dimensional roles of sodium-glucose cotransporter 2 inhibitors: beyond hypoglycemic and cardiorenal protection. [PDF]

Front Endocrinol (Lausanne)
Li S, Wang Y, Gong Q.
europepmc   +1 more source

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection. [PDF]

JACC Basic Transl Sci, 2020
Herat LY, Magno AL, Rudnicka C, Hricova J, Carnagarin R, Ward NC, Arcambal A, Kiuchi MG, Head GA, Schlaich MP, Matthews VB.   +10 more
europepmc   +1 more source

Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional study. [PDF]

Cardiovasc Diabetol
Zhao Z, Zheng N, Zhang T, Zhang C, Li Y, Lan M, Zhang N, Li H, Ai H, Liu D.   +9 more
europepmc   +1 more source

Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection

Journal of the American College of Cardiology, 2019
David Z. Cherney, Ayodele Odutayo, Ronnie Aronson, Justin Ezekowitz, John D. Parker   +4 more
openaire   +1 more source

Modeling Cardiorenal Protection with Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes: An Analysis of DEPICT-1 and DEPICT-2. [PDF]

Clin J Am Soc Nephrol
Nardone M, Kugathasan L, Sridhar VS, Dutta P, Campbell DJT, Layton AT, Perkins BA, Barbour S, Lam TKT, Levin A, Lovblom LE, Mucsi I, Rabasa-Lhoret R, Rac VE, Senior P, Sigal RJ, Stanimirovic A, Persson F, Stougaard EB, Doria A, Cherney DZI.   +20 more
europepmc   +1 more source

A new potential mode of cardiorenal protection of KLOTHO gene variability in type 1 diabetic adolescents. [PDF]

J Mol Med (Berl), 2020
Słomiński B, Ryba-Stanisławowska M, Skrzypkowska M, Gabig-Cimińska M, Myśliwiec M.   +4 more
europepmc   +1 more source

SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice. [PDF]

Front Pharmacol
Martos-Guillami N, Vergara A, Llorens-Cebrià C, Motto AE, Martínez-Díaz I, Gonçalves F, Garcias-Ramis MM, Allo-Urzainqui E, Narváez A, Bermejo S, Muñoz V, León-Román J, Ferrer-Costa R, Jacobs-Cachá C, Vilardell-Vilà J, Soler MJ.   +15 more
europepmc   +1 more source

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection. [PDF]

J Bras Nefrol, 2020
Sridhar VS, Dubrofsky L, Boulet J, Cherney DZ.   +3 more
europepmc   +1 more source

Role of Glycosuria in SGLT2 Inhibitor-Induced Cardiorenal Protection: A Mechanistic Analysis of the CREDENCE Trial. [PDF]

Diabetes
Ferrannini E, Solini A, Baldi S, Scozzaro T, Polidori D, Natali A, Hansen MK.   +6 more
europepmc   +1 more source

Cardiorenal protection in advanced chronic kidney disease: research highlights from landmark papers published in Nephrology Dialysis Transplantation during 2018. [PDF]

Nephrol Dial Transplant, 2020
Georgianos PI, Agarwal R.
europepmc   +1 more source